Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

The steroid solution can regrow hair but often causes skin issues and doesn't work long-term.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

WNT10A mutations cause varied symptoms in patients with odonto-onycho-dermal dysplasia.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Hair transplants can effectively treat hair loss from CCCA in African American women if there's no inflammation.

The document concludes that accurate diagnosis of hair loss in children is crucial due to limited treatment options and the condition's psychological impact.

A mother and son both had ulcerative colitis and alopecia, suggesting a genetic link in autoimmune disorders and successful treatment with cyclosporine.

New psoriasis treatments are effective but come with side effects and risks.

Different treatments for alopecia areata have unpredictable results and varying success rates.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

Oral retinoids may help some patients with hard-to-treat lichen planopilaris, but more research is needed.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Adalimumab helped control a child's severe eye disease when other treatments failed.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

Platelet-rich plasma is tolerable for lichen planopilaris and doesn't worsen the condition, but its effectiveness is unclear.

Some topical treatments like corticosteroids and vitamin D analogues are effective for scalp psoriasis, but more long-term data is needed.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

People with pemphigus vulgaris and pemphigus foliaceus often have smaller sebaceous glands on their scalp.

A woman with a rare type of dermatomyositis improved with low-dose prednisone and methotrexate.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.

The document concludes that patients with skin of color need specialized dermatological care and education to manage unique skin conditions effectively.

Minoxidil caused a severe rash in a patient, which improved after stopping the drug.

Nitrofurantoin may cause sub-acute cutaneous lupus erythematosus.

Microsponges delivery system is a safe, versatile method for controlled drug release in various treatments.

Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.

No treatment reliably changes Alopecia Areata's course; reassurance and possibly a wig are recommended.